Home ➤ Life Science ➤ Diagnostics ➤ Reproductive Genetics Market
Reproductive Genetics Market
Published date: Feb 2024 • Formats:
Request Sample Schedule a Call

Global Reproductive Genetics Market By Procedure Type-(Pre-Natal Screening, Pre-Implantation Genetic Testing, Infertility Genetic Testing, Carrier Screening) By Product Type-(Kits, Laboratory Developed Tests (LDT), Reagents and Consumables) By Application-(Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, Other Applications) By Technology-(PCR, Next-Generation Sequencing, In-Situ Hybridization (ISH), Microarray) and by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

  • Published date: Feb 2024
  • Report ID: 84850
  • Number of Pages: 340
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Taxonomy
      • 1.3. Research Scope
      • 1.4. Key Analysis
      • 1.5. Key Findings by Major Segments
      • 1.6. Top strategies by Major Players
    • 2. North America & Europe Reproductive Genetics Overview
      • 2.1. Reproductive Genetics Dynamics
        • 2.1.1. Drivers
        • 2.1.2. Opportunities
        • 2.1.3. Restraints
        • 2.1.4. Challenges
      • 2.2. Macro-economic Factors
      • 2.3. Regulatory Framework
      • 2.4. Market Investment Feasibility Index
      • 2.5. PEST Analysis
      • 2.6. PORTER’S Five Force Analysis
      • 2.7. Drivers & Restraints Impact Analysis
      • 2.8. Industry Chain Analysis
      • 2.9. Cost Structure Analysis
      • 2.10. Marketing Strategy
      • 2.11. Russia-Ukraine War Impact Analysis
      • 2.12. Opportunity Map Analysis
      • 2.13. Market Competition Scenario Analysis
      • 2.14. Product Life Cycle Analysis
      • 2.15. Opportunity Orbits
      • 2.16. Manufacturer Intensity Map
      • 2.17. Major Companies' sales by Value & Volume
    • 3. North America & Europe Reproductive Genetics Analysis, Opportunity and Forecast, 2016-2032
      • 3.1. North America & Europe Reproductive Genetics Analysis, 2016-2021
      • 3.2. North America & Europe Reproductive Genetics Opportunity and Forecast, 2023-2032
      • 3.3. North America & Europe Reproductive Genetics Analysis, Opportunity and Forecast, By Procedure Type, 2016-2032
        • 3.3.1. North America & Europe Reproductive Genetics Analysis by Procedure Type: Introduction
        • 3.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Procedure Type, 2016-2032
        • 3.3.3. Carrier Screening
          • 3.3.3.1. Carrier Screening1
          • 3.3.3.2. Carrier Screening2
        • 3.3.4. Pre-Natal Screening
        • 3.3.5. Pre-Implantation Genetic Testing
        • 3.3.6. Infertility Genetic Testing
      • 3.4. North America & Europe Reproductive Genetics Analysis, Opportunity and Forecast, By Product Type, 2016-2032
        • 3.4.1. North America & Europe Reproductive Genetics Analysis by Product Type: Introduction
        • 3.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product Type, 2016-2032
        • 3.4.3. Kits
        • 3.4.4. Laboratory Developed Tests
        • 3.4.5. Reagents & Consumables
      • 3.5. North America & Europe Reproductive Genetics Analysis, Opportunity and Forecast, By Technology, 2016-2032
        • 3.5.1. North America & Europe Reproductive Genetics Analysis by Technology: Introduction
        • 3.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Technology, 2016-2032
        • 3.5.3. Next Generation Sequencing
        • 3.5.4. Polymerase Chain Reaction
        • 3.5.5. In-Situ Hybridization
        • 3.5.6. Microarray
      • 3.6. North America & Europe Reproductive Genetics Analysis, Opportunity and Forecast, By Application, 2016-2032
        • 3.6.1. North America & Europe Reproductive Genetics Analysis by Application: Introduction
        • 3.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Application, 2016-2032
        • 3.6.3. Aneuploidy
        • 3.6.4. Structural Chromosomal Abnormality
        • 3.6.5. Single Gene Disorder
        • 3.6.6. Other Applications
    • 4. North America Reproductive Genetics Analysis, Opportunity and Forecast, 2016-2032
      • 4.1. North America Reproductive Genetics Analysis, 2016-2021
      • 4.2. North America Reproductive Genetics Opportunity and Forecast, 2023-2032
      • 4.3. North America Reproductive Genetics Analysis, Opportunity, and Forecast, By Procedure Type, 2016-2032
        • 4.3.1. North America Reproductive Genetics Analysis by Procedure Type: Introduction
        • 4.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Procedure Type, 2016-2032
        • 4.3.3. Carrier Screening
          • 4.3.3.1. Carrier Screening1
          • 4.3.3.2. Carrier Screening2
        • 4.3.4. Pre-Natal Screening
        • 4.3.5. Pre-Implantation Genetic Testing
        • 4.3.6. Infertility Genetic Testing
      • 4.4. North America Reproductive Genetics Analysis, Opportunity, and Forecast, By Product Type, 2016-2032
        • 4.4.1. North America Reproductive Genetics Analysis by Product Type: Introduction
        • 4.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product Type, 2016-2032
        • 4.4.3. Kits
        • 4.4.4. Laboratory Developed Tests
        • 4.4.5. Reagents & Consumables
      • 4.5. North America Reproductive Genetics Analysis, Opportunity and Forecast, By Technology, 2016-2032
        • 4.5.1. North America Reproductive Genetics Analysis by Technology: Introduction
        • 4.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Technology, 2016-2032
        • 4.5.3. Next Generation Sequencing
        • 4.5.4. Polymerase Chain Reaction
        • 4.5.5. In-Situ Hybridization
        • 4.5.6. Microarray
      • 4.6. North America Reproductive Genetics Analysis, Opportunity, and Forecast, By Application, 2016-2032
        • 4.6.1. North America Reproductive Genetics Analysis by Application: Introduction
        • 4.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Application, 2016-2032
        • 4.6.3. Aneuploidy
        • 4.6.4. Structural Chromosomal Abnormality
        • 4.6.5. Single Gene Disorder
        • 4.6.6. Other Applications
      • 4.7. North America Reproductive Genetics Analysis, Opportunity and Forecast, By Country, 2016-2032
        • 4.7.1. North America Reproductive Genetics Analysis by Country: Introduction
        • 4.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country, 2016-2032
          • 4.7.2.1. The U.S.
          • 4.7.2.2. Canada
          • 4.7.2.3. Mexico
    • 5. Europe Reproductive Genetics Analysis, Opportunity and Forecast, 2016-2032
      • 5.1. Europe Reproductive Genetics Analysis, 2016-2021
      • 5.2. Europe Reproductive Genetics Opportunity and Forecast, 2023-2032
      • 5.3. Europe Reproductive Genetics Analysis, Opportunity, and Forecast, By Procedure Type, 2016-2032
        • 5.3.1. Europe Reproductive Genetics Analysis by Procedure Type: Introduction
        • 5.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Procedure Type, 2016-2032
        • 5.3.3. Carrier Screening
          • 5.3.3.1. Carrier Screening1
          • 5.3.3.2. Carrier Screening2
        • 5.3.4. Pre-Natal Screening
        • 5.3.5. Pre-Implantation Genetic Testing
        • 5.3.6. Infertility Genetic Testing
      • 5.4. Europe Reproductive Genetics Analysis, Opportunity, and Forecast, By Product Type, 2016-2032
        • 5.4.1. Europe Reproductive Genetics Analysis by Product Type: Introduction
        • 5.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product Type, 2016-2032
        • 5.4.3. Kits
        • 5.4.4. Laboratory Developed Tests
        • 5.4.5. Reagents & Consumables
      • 5.5. Europe Reproductive Genetics Analysis, Opportunity and Forecast, By Technology, 2016-2032
        • 5.5.1. Europe Reproductive Genetics Analysis by Technology: Introduction
        • 5.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Technology, 2016-2032
        • 5.5.3. Next Generation Sequencing
        • 5.5.4. Polymerase Chain Reaction
        • 5.5.5. In-Situ Hybridization
        • 5.5.6. Microarray
      • 5.6. Europe Reproductive Genetics Analysis, Opportunity, and Forecast, By Application, 2016-2032
        • 5.6.1. Europe Reproductive Genetics Analysis by Application: Introduction
        • 5.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Application, 2016-2032
        • 5.6.3. Aneuploidy
        • 5.6.4. Structural Chromosomal Abnormality
        • 5.6.5. Single Gene Disorder
        • 5.6.6. Other Applications
      • 5.7. Europe Reproductive Genetics Analysis, Opportunity and Forecast, By Country, 2016-2032
        • 5.7.1. Europe Reproductive Genetics Analysis by Country: Introduction
        • 5.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country, 2016-2032
          • 5.7.2.1. U.K.
          • 5.7.2.2. Germany
          • 5.7.2.3. France
          • 5.7.2.4. Spain
          • 5.7.2.5. Italy
          • 5.7.2.6. Russia
          • 5.7.2.7. Rest of Europe
    • 6. North America & Europe Reproductive Genetics Analysis, Opportunity and Forecast, By Region, 2016-2032
      • 6.1. North America & Europe Reproductive Genetics Analysis by Region: Introduction
      • 6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Region, 2016-2032
        • 6.2.1. North America
        • 6.2.2. Europe
    • 7. North America & Europe Reproductive Genetics Competitive Landscape, Market Share Analysis, and Company Profiles
      • 7.1. Market Share Analysis
      • 7.2. Company Profiles
      • 7.3. Agilent Technologies Inc.
        • 7.3.1. Company Overview
        • 7.3.2. Financial Highlights
        • 7.3.3. Product Portfolio
        • 7.3.4. SWOT Analysis
        • 7.3.5. Key Strategies and Developments
      • 7.4. BGI, CENTOGENE AG
        • 7.4.1. Company Overview
        • 7.4.2. Financial Highlights
        • 7.4.3. Product Portfolio
        • 7.4.4. SWOT Analysis
        • 7.4.5. Key Strategies and Developments
      • 7.5. Fulgent Genetics Inc.
        • 7.5.1. Company Overview
        • 7.5.2. Financial Highlights
        • 7.5.3. Product Portfolio
        • 7.5.4. SWOT Analysis
        • 7.5.5. Key Strategies and Developments
      • 7.6. F. Hoffmann-La Roche Ltd
        • 7.6.1. Company Overview
        • 7.6.2. Financial Highlights
        • 7.6.3. Product Portfolio
        • 7.6.4. SWOT Analysis
        • 7.6.5. Key Strategies and Developments
      • 7.7. Igenomix
        • 7.7.1. Company Overview
        • 7.7.2. Financial Highlights
        • 7.7.3. Product Portfolio
        • 7.7.4. SWOT Analysis
        • 7.7.5. Key Strategies and Developments
      • 7.8. Illumina Inc.
        • 7.8.1. Company Overview
        • 7.8.2. Financial Highlights
        • 7.8.3. Product Portfolio
        • 7.8.4. SWOT Analysis
        • 7.8.5. Key Strategies and Developments
      • 7.9. Invitae Corporation
        • 7.9.1. Company Overview
        • 7.9.2. Financial Highlights
        • 7.9.3. Product Portfolio
        • 7.9.4. SWOT Analysis
        • 7.9.5. Key Strategies and Developments
      • 7.10. Laboratory Corporation of America Holdings
        • 7.10.1. Company Overview
        • 7.10.2. Financial Highlights
        • 7.10.3. Product Portfolio
        • 7.10.4. SWOT Analysis
        • 7.10.5. Key Strategies and Developments
      • 7.11. PerkinElmer Inc.
        • 7.11.1. Company Overview
        • 7.11.2. Financial Highlights
        • 7.11.3. Product Portfolio
        • 7.11.4. SWOT Analysis
        • 7.11.5. Key Strategies and Developments
      • 7.12. Myriad Genetics Inc.
        • 7.12.1. Company Overview
        • 7.12.2. Financial Highlights
        • 7.12.3. Product Portfolio
        • 7.12.4. SWOT Analysis
        • 7.12.5. Key Strategies and Developments
      • 7.13. OPKO Health Inc.
        • 7.13.1. Company Overview
        • 7.13.2. Financial Highlights
        • 7.13.3. Product Portfolio
        • 7.13.4. SWOT Analysis
        • 7.13.5. Key Strategies and Developments
      • 7.14. Quest Diagnostics
        • 7.14.1. Company Overview
        • 7.14.2. Financial Highlights
        • 7.14.3. Product Portfolio
        • 7.14.4. SWOT Analysis
        • 7.14.5. Key Strategies and Developments
      • 7.15. QIAGEN N.V.
        • 7.15.1. Company Overview
        • 7.15.2. Financial Highlights
        • 7.15.3. Product Portfolio
        • 7.15.4. SWOT Analysis
        • 7.15.5. Key Strategies and Developments
      • 7.16. Thermo Fisher Scientific Inc.
        • 7.16.1. Company Overview
        • 7.16.2. Financial Highlights
        • 7.16.3. Product Portfolio
        • 7.16.4. SWOT Analysis
        • 7.16.5. Key Strategies and Developments
    • 8. Assumptions and Acronyms
    • 9. Research Methodology
    • 10. Contact

     

    • List of Figures
      • Figure 1: North America & Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Procedure Type in 2022
      • Figure 2: North America & Europe Reproductive Genetics Market Attractiveness Analysis by Procedure Type, 2016-2032
      • Figure 3: North America & Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Product Type in 2022
      • Figure 4: North America & Europe Reproductive Genetics Market Attractiveness Analysis by Product Type, 2016-2032
      • Figure 5: North America & Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Technology in 2022
      • Figure 6: North America & Europe Reproductive Genetics Market Attractiveness Analysis by Technology, 2016-2032
      • Figure 7: North America & Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Application in 2022
      • Figure 8: North America & Europe Reproductive Genetics Market Attractiveness Analysis by Application, 2016-2032
      • Figure 9: North America & Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Region in 2022
      • Figure 10: North America & Europe Reproductive Genetics Market Attractiveness Analysis by Region, 2016-2032
      • Figure 11: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) (2016-2032)
      • Figure 12: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Region (2016-2032)
      • Figure 13: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Procedure Type (2016-2032)
      • Figure 14: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
      • Figure 15: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
      • Figure 16: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Application (2016-2032)
      • Figure 17: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
      • Figure 18: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Procedure Type (2016-2032)
      • Figure 19: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
      • Figure 20: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
      • Figure 21: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
      • Figure 22: North America & Europe Reproductive Genetics Market Share Comparison by Region (2016-2032)
      • Figure 23: North America & Europe Reproductive Genetics Market Share Comparison by Procedure Type (2016-2032)
      • Figure 24: North America & Europe Reproductive Genetics Market Share Comparison by Product Type (2016-2032)
      • Figure 25: North America & Europe Reproductive Genetics Market Share Comparison by Technology (2016-2032)
      • Figure 26: North America & Europe Reproductive Genetics Market Share Comparison by Application (2016-2032)
      • Figure 27: North America Reproductive Genetics Revenue (US$ Mn) Market Share by Procedure Type 2022
      • Figure 28: North America Reproductive Genetics Market Attractiveness Analysis by Procedure Type, 2016-2032
      • Figure 29: North America Reproductive Genetics Revenue (US$ Mn) Market Share by Product Type in 2022
      • Figure 30: North America Reproductive Genetics Market Attractiveness Analysis by Product Type, 2016-2032
      • Figure 31: North America Reproductive Genetics Revenue (US$ Mn) Market Share by Technology in 2022
      • Figure 32: North America Reproductive Genetics Market Attractiveness Analysis by Technology, 2016-2032
      • Figure 33: North America Reproductive Genetics Revenue (US$ Mn) Market Share by Application in 2022
      • Figure 34: North America Reproductive Genetics Market Attractiveness Analysis by Application, 2016-2032
      • Figure 35: North America Reproductive Genetics Revenue (US$ Mn) Market Share by Country in 2022
      • Figure 36: North America Reproductive Genetics Market Attractiveness Analysis by Country, 2016-2032
      • Figure 37: North America Reproductive Genetics Market Revenue (US$ Mn) (2016-2032)
      • Figure 38: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Figure 39: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Procedure Type (2016-2032)
      • Figure 40: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
      • Figure 41: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
      • Figure 42: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Application (2016-2032)
      • Figure 43: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Figure 44: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Procedure Type (2016-2032)
      • Figure 45: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
      • Figure 46: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
      • Figure 47: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
      • Figure 48: North America Reproductive Genetics Market Share Comparison by Country (2016-2032)
      • Figure 49: North America Reproductive Genetics Market Share Comparison by Procedure Type (2016-2032)
      • Figure 50: North America Reproductive Genetics Market Share Comparison by Product Type (2016-2032)
      • Figure 51: North America Reproductive Genetics Market Share Comparison by Technology (2016-2032)
      • Figure 52: North America Reproductive Genetics Market Share Comparison by Application (2016-2032)
      • Figure 53: Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Procedure Type in 2022
      • Figure 54: Europe Reproductive Genetics Market Attractiveness Analysis by Procedure Type, 2016-2032
      • Figure 55: Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Product Type in 2022
      • Figure 56: Europe Reproductive Genetics Market Attractiveness Analysis by Product Type, 2016-2032
      • Figure 57: Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Technology in 2022
      • Figure 58: Europe Reproductive Genetics Market Attractiveness Analysis by Technology, 2016-2032
      • Figure 59: Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Application in 2022
      • Figure 60: Europe Reproductive Genetics Market Attractiveness Analysis by Application, 2016-2032
      • Figure 61: Europe Reproductive Genetics Revenue (US$ Mn) Market Share by Country in 2022
      • Figure 62: Europe Reproductive Genetics Market Attractiveness Analysis by Country, 2016-2032
      • Figure 63: Europe Reproductive Genetics Market Revenue (US$ Mn) (2016-2032)
      • Figure 64: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Figure 65: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Procedure Type (2016-2032)
      • Figure 66: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
      • Figure 67: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
      • Figure 68: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Application (2016-2032)
      • Figure 69: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Figure 70: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Procedure Type (2016-2032)
      • Figure 71: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
      • Figure 72: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
      • Figure 73: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
      • Figure 74: Europe Reproductive Genetics Market Share Comparison by Country (2016-2032)
      • Figure 75: Europe Reproductive Genetics Market Share Comparison by Procedure Type (2016-2032)
      • Figure 76: Europe Reproductive Genetics Market Share Comparison by Product Type (2016-2032)
      • Figure 77: Europe Reproductive Genetics Market Share Comparison by Technology (2016-2032)
      • Figure 78: Europe Reproductive Genetics Market Share Comparison by Application (2016-2032)

       

    • List of Tables
      • Table 1: North America & Europe Reproductive Genetics Market Comparison by Procedure Type (2016-2032)
      • Table 2: North America & Europe Reproductive Genetics Market Comparison by Product Type (2016-2032)
      • Table 3: North America & Europe Reproductive Genetics Market Comparison by Technology (2016-2032)
      • Table 4: North America & Europe Reproductive Genetics Market Comparison by Application (2016-2032)
      • Table 5: North America & Europe Reproductive Genetics Revenue (US$ Mn) Comparison by Region (2016-2032)
      • Table 6: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) (2016-2032)
      • Table 7: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Region (2016-2032)
      • Table 8: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Procedure Type (2016-2032)
      • Table 9: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
      • Table 10: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
      • Table 11: North America & Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Application (2016-2032)
      • Table 12: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
      • Table 13: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Procedure Type (2016-2032)
      • Table 14: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
      • Table 15: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
      • Table 16: North America & Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
      • Table 17: North America & Europe Reproductive Genetics Market Share Comparison by Region (2016-2032)
      • Table 18: North America & Europe Reproductive Genetics Market Share Comparison by Procedure Type (2016-2032)
      • Table 19: North America & Europe Reproductive Genetics Market Share Comparison by Product Type (2016-2032)
      • Table 20: North America & Europe Reproductive Genetics Market Share Comparison by Technology (2016-2032)
      • Table 21: North America & Europe Reproductive Genetics Market Share Comparison by Application (2016-2032)
      • Table 22: North America Reproductive Genetics Market Comparison by Product Type (2016-2032)
      • Table 23: North America Reproductive Genetics Market Comparison by Technology (2016-2032)
      • Table 24: North America Reproductive Genetics Market Comparison by Application (2016-2032)
      • Table 25: North America Reproductive Genetics Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 26: North America Reproductive Genetics Market Revenue (US$ Mn) (2016-2032)
      • Table 27: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 28: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Procedure Type (2016-2032)
      • Table 29: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
      • Table 30: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
      • Table 31: North America Reproductive Genetics Market Revenue (US$ Mn) Comparison by Application (2016-2032)
      • Table 32: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Table 33: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Procedure Type (2016-2032)
      • Table 34: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
      • Table 35: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
      • Table 36: North America Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
      • Table 37: North America Reproductive Genetics Market Share Comparison by Country (2016-2032)
      • Table 38: North America Reproductive Genetics Market Share Comparison by Procedure Type (2016-2032)
      • Table 39: North America Reproductive Genetics Market Share Comparison by Product Type (2016-2032)
      • Table 40: North America Reproductive Genetics Market Share Comparison by Technology (2016-2032)
      • Table 41: North America Reproductive Genetics Market Share Comparison by Application (2016-2032)
      • Table 42: Europe Reproductive Genetics Market Comparison by Procedure Type (2016-2032)
      • Table 43: Europe Reproductive Genetics Market Comparison by Product Type (2016-2032)
      • Table 44: Europe Reproductive Genetics Market Comparison by Technology (2016-2032)
      • Table 45: Europe Reproductive Genetics Market Comparison by Application (2016-2032)
      • Table 46: Europe Reproductive Genetics Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 47: Europe Reproductive Genetics Market Revenue (US$ Mn) (2016-2032)
      • Table 48: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Country (2016-2032)
      • Table 49: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Procedure Type (2016-2032)
      • Table 50: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
      • Table 51: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
      • Table 52: Europe Reproductive Genetics Market Revenue (US$ Mn) Comparison by Application (2016-2032)
      • Table 53: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
      • Table 54: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Procedure Type (2016-2032)
      • Table 55: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
      • Table 56: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
      • Table 57: Europe Reproductive Genetics Market Y-o-Y Growth Rate Comparison by Application (2016-2032)
      • Table 58: Europe Reproductive Genetics Market Share Comparison by Country (2016-2032)
      • Table 59: Europe Reproductive Genetics Market Share Comparison by Procedure Type (2016-2032)
      • Table 60: Europe Reproductive Genetics Market Share Comparison by Product Type (2016-2032)
      • Table 61: Europe Reproductive Genetics Market Share Comparison by Technology (2016-2032)
      • Table 62: Europe Reproductive Genetics Market Share Comparison by Application (2016-2032)
    • Invitae Corporation
    • Laboratory Corporation of America Holdings
    • PerkinElmer, Inc.
    • Myriad Genetics, Inc.
    • OPKO Health, Inc.
    • Quest Diagnostics
    • QIAGEN N.V.
    • Thermo Fisher Scientific Company Profile
    • Agilent Technologies, Inc.
    • BGI
    • CENTOGENE AG
    • Fulgent Genetics, Inc.
    • F. Hoffmann-La Roche Ltd
    • Igenomix, Illumina, Inc.
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Reproductive Genetics Market
  • 84850
  • Feb 2024
    • ★★★★★
      ★★★★★
    • (60)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options